Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019

SELL
$35.77 - $40.57 $313,667 - $355,758
-8,769 Closed
0 $0
Q4 2018

Oct 03, 2024

BUY
$31.89 - $38.44 $279,643 - $337,080
8,769 New
8,769 $331,000
Q4 2018

Feb 06, 2019

SELL
$31.89 - $38.44 $333,122 - $401,544
-10,446 Reduced 54.36%
8,769 $331,000
Q3 2018

Oct 04, 2024

BUY
$29.25 - $36.73 $562,038 - $705,766
19,215 New
19,215 $665,000
Q3 2018

Nov 13, 2018

SELL
$29.25 - $36.73 $9,272 - $11,643
-317 Reduced 1.62%
19,215 $665,000
Q2 2018

Oct 04, 2024

BUY
$28.49 - $35.06 $556,466 - $684,791
19,532 New
19,532 $629,000
Q2 2018

Aug 10, 2018

SELL
$28.49 - $35.06 $154,900 - $190,621
-5,437 Reduced 21.78%
19,532 $629,000
Q1 2018

Oct 04, 2024

BUY
$31.93 - $39.54 $277,375 - $343,483
8,687 Added 53.35%
24,969 $816,000
Q1 2018

May 01, 2018

BUY
$31.93 - $39.54 $277,375 - $343,483
8,687 Added 53.35%
24,969 $816,000
Q4 2017

Oct 04, 2024

BUY
$34.15 - $37.62 $556,030 - $612,528
16,282 New
16,282 $612,000
Q4 2017

Jan 26, 2018

SELL
$34.15 - $37.62 $13,420 - $14,784
-393 Reduced 2.36%
16,282 $612,000
Q3 2017

Nov 13, 2017

BUY
$30.11 - $37.72 $4,877 - $6,110
162 Added 0.98%
16,675 $595,000
Q2 2017

Aug 09, 2017

BUY
N/A
16,513
16,513 $696,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.47B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.